Summary & Overview
CPT 0341U: Single Cell Prenatal Diagnosis (SCPD) Test
CPT code 0341U designates a proprietary laboratory test — the Single Cell Prenatal Diagnosis (SCPD) Test from Luna Genetics Inc. — that isolates fetal cells from maternal blood early in pregnancy for DNA sequencing to detect aneuploidies, duplication/deletion variants, and mosaicism. As a PLA code, 0341U identifies a single manufacturer-specific assay and is used in claims when reporting this unique test. Nationally, proprietary prenatal genomic assays are increasingly relevant to prenatal care pathways and payer coverage discussions due to their potential to offer earlier, noninvasive genomic diagnosis.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and common billing practices for PLA codes, a summary of payer patterns and benchmarks where available, and clinical context about the SCPD Test’s intended use and service setting. The publication also highlights coding specifics for claim submission and lists commonly used modifiers. This analysis is presented for a national audience and focuses on payer coverage frameworks, clinical implications of single-cell prenatal sequencing, and operational considerations for laboratories and providers submitting CPT code 0341U.
Billing Code Overview
CPT code 0341U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the Single Cell Prenatal Diagnosis (SCPD) Test from Luna Genetics Inc. The assay uses a maternal blood sample collected early in pregnancy to isolate fetal cells for DNA sequencing. The test evaluates fetal cells for aneuploidies, duplication/deletion variants, and mosaicism.
Service Type: Laboratory — cell-free fetal cell isolation and genomic sequencing
Typical Site of Service: Clinical laboratory or reference laboratory; maternal blood draw performed in outpatient clinic or phlebotomy setting
Clinical & Coding Specifications
Clinical Context
A 34-year-old pregnant person at 9 weeks' gestation presents for early noninvasive prenatal testing because of advanced maternal age and an earlier pregnancy with a chromosomal abnormality. The obstetrics provider orders the Single Cell Prenatal Diagnosis (SCPD) Test (0341U) from Luna Genetics Inc. A maternal blood draw is obtained in an outpatient antepartum clinic or a specialty prenatal diagnostic laboratory collection site. The sample is shipped to the performing laboratory where fetal cells are isolated from maternal blood, DNA is sequenced, and results are analyzed for common aneuploidies, subchromosomal duplications/deletions, and fetal mosaicism. Results are reported back to the ordering obstetrician or maternal–fetal medicine specialist to inform counseling and decisions about potential diagnostic testing (for example, chorionic villus sampling or amniocentesis), pregnancy management, and genetic counseling referrals.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional/interpretive portion of the test by a qualified laboratory director or molecular pathologist. |
TC |